| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ALDER BIOPHARMACEUTICALS INC | 1,600,183 | 39,957,000 | 27.42% | ||
| 2 | AERIE PHARMACEUTICALS INC | 1,345,313 | 23,678,000 | 16.25% | ||
| 3 | WAVE LIFE SCIENCES LTD | 970,104 | 20,071,000 | 13.77% | ||
| 4 | INTELLIA THERAPEUTICS INC | 763,688 | 16,305,000 | 11.19% | ||
| 5 | GLOBAL BLOOD THERAPEUTICS IN COM | 690,269 | 11,452,000 | 7.86% | ||
| 6 | ARDELYX INC COM | 601,485 | 5,251,000 | 3.60% | ||
| 7 | EPIZYME INC COM | 511,777 | 5,241,000 | 3.60% | ||
| 8 | AVEXIS INC COM | 95,173 | 3,618,000 | 2.48% | ||
| 9 | NEURODERM LTD | 201,469 | 3,274,000 | 2.25% | ||
| 10 | ZAFGEN INC COM | 537,495 | 3,220,000 | 2.21% | ||
| 11 | SYROS PHARMACEUTICALS INC | 150,000 | 2,723,000 | 1.87% | ||
| 12 | BELLICUM PHARMACEUTICALS INC COM | 205,990 | 2,670,000 | 1.83% | ||
| 13 | AKARI THERAPEUTICS PLC | 197,072 | 2,659,000 | 1.82% | ||
| 14 | AIMMUNE THERAPEUTICS INC COM | 235,020 | 2,543,000 | 1.74% | ||
| 15 | Orexigen Therapeutics, Inc. | 2,542,575 | 1,093,000 | 0.75% | ||
| 16 | LIPOCINE INC NEW | 302,640 | 920,000 | 0.63% | ||
| 17 | NANOSTRING TECHNOLOGIES INC | 71,000 | 895,000 | 0.61% | ||
| 18 | BioDelivery Sciences International Inc | 70,177 | 166,000 | 0.11% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-118727, filed 2016.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
